Omega Therapeutics, Inc.Omega Therapeutics, Inc.Omega Therapeutics, Inc.

Omega Therapeutics, Inc.

No trades
See on Supercharts
Market capitalization
‪132.37 M‬USD
−1.81USD
‪−97.43 M‬USD
‪3.09 M‬USD
‪20.42 M‬
Beta (1Y)
1.64

About Omega Therapeutics, Inc.

CEO
Mahesh Karande
Headquarters
Cambridge
Employees (FY)
94
Founded
2016
ISIN
US68217N1054
FIGI
BBG00WCNQZN4
Omega Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of DNA-sequence-targeting and mRNA-encoded therapeutics. It offers its product under the OMEGA platform. The company was founded by Noubar B. Afeyan and David Berry on July 13, 2016 and is headquartered in Cambridge, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of OMGA is 2.40 USD — it has decreased by 0.83% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Omega Therapeutics, Inc. stocks are traded under the ticker OMGA.
Omega Therapeutics, Inc. is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
OMGA stock is 4.66% volatile and has beta coefficient of 1.64. Check out the list of the most volatile stocks — is Omega Therapeutics, Inc. there?
One year price forecast for Omega Therapeutics, Inc. has a max estimate of 15.00 USD and a min estimate of 7.00 USD.
OMGA earnings for the last quarter are −0.40 USD per share, whereas the estimation was −0.53 USD resulting in a 24.32% surprise. The estimated earnings for the next quarter are −0.45 USD per share. See more details about Omega Therapeutics, Inc. earnings.
Omega Therapeutics, Inc. revenue for the last quarter amounts to ‪831.00 K‬ USD despite the estimated figure of ‪442.86 K‬ USD. In the next quarter revenue is expected to reach ‪450.00 K‬ USD.
Yes, you can track Omega Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
OMGA stock has fallen by 18.37% compared to the previous week, the month change is a 29.62% fall, over the last year Omega Therapeutics, Inc. has showed a 72.73% decrease.
OMGA net income for the last quarter is ‪−20.21 M‬ USD, while the quarter before that showed ‪−22.25 M‬ USD of net income which accounts for 9.14% change. Track more Omega Therapeutics, Inc. financial stats to get the full picture.
Today Omega Therapeutics, Inc. has the market capitalization of ‪132.37 M‬, it has increased by 2.66% over the last week.
No, OMGA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, OMGA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Omega Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
OMGA reached its all-time high on Nov 1, 2021 with the price of 31.41 USD, and its all-time low was 1.30 USD and was reached on Nov 1, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 21, 2024, the company has 94.00 employees. See our rating of the largest employees — is Omega Therapeutics, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Omega Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Omega Therapeutics, Inc. stock shows the sell signal. See more of Omega Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Omega Therapeutics, Inc. future price: according to them, OMGA price has a max estimate of 15.00 USD and a min estimate of 7.00 USD. Read a more detailed Omega Therapeutics, Inc. forecast: see what analysts think of Omega Therapeutics, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Omega Therapeutics, Inc. EBITDA is ‪−93.49 M‬ USD, and current EBITDA margin is ‪−3.02 K‬%. See more stats in Omega Therapeutics, Inc. financial statements.